CLN5 and neuronal ceroid lipofuscinosis 5: Recessive mutations in CLN5 are associated with neuronal ceroid lipofuscinosis-5, a syndrome characterized by ataxia, seizures, myoclonus, visual impairment and cognitive/motor decline.